Literature DB >> 1270131

Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid.

A M Svennerholm, J Holmgren.   

Abstract

Subcutaneous immunization of rabbits with a combination of Vibrio cholerae lipopolysaccharide (LPS) and enterotoxin induced a more than 100-fold-higher degree of protection against intestinal challenge with live cholera vibrios than did vaccination with either of the two antigens alone. Such a synergistic effect was also obtained by immunization with a combination of LPS and choleragenoid. The immunization with LPS and toxin (or toxoid) in combination did not enhance the reistance to toxin challenge above that induced by the toxin component alone. This, together with data from titrations of anti-LPS and antitoxin antibodies in serum and in intestinal washings, contradicts enhanced immune responses due to adjuvant action of the two antigens as the explanation for the synergistic effect of the combined vaccines. A more likely explanation would be that the antibacterial and antitoxic immune responses, without being increased in themselves, function synergistically by interfering with two separate events in cholera pathogensis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270131      PMCID: PMC420671          DOI: 10.1128/iai.13.3.735-740.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Immunochemical Studies of Two Cholera Toxin-Containing Standard Culture Filtrate Preparations of Vibrio cholerae.

Authors:  J Holmgren; I Lönnroth; O Ouchterlony
Journal:  Infect Immun       Date:  1971-06       Impact factor: 3.441

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Antitoxic immunity in experimental cholera: comparison of immunity induced perorally and parenterally in mice.

Authors:  K Fujita; R A Finkelstein
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

4.  Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony; A Anderson; G Walletström; U Westerberg-Berndtsson
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

5.  Quantitation of vibriocidal antibodies using agar plague techniques.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

6.  The antigens of Vibrio cholerae involved in the vibriocidal action of antibody and complement.

Authors:  S H Neoh; D Rowley
Journal:  J Infect Dis       Date:  1970-05       Impact factor: 5.226

7.  Cholera infection and toxin in the rabbit ileal loop.

Authors:  W Burrows; G M Musteikis
Journal:  J Infect Dis       Date:  1966-04       Impact factor: 5.226

8.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

9.  Oligomeric structure of cholera toxin: characteristics of the H and L subunits.

Authors:  J Holmgren; I Lonnroth
Journal:  J Gen Microbiol       Date:  1975-01

10.  Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.

Authors:  A S Benenson; W H Mosley; M Fahimuddin; R O Oseasohn
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

View more
  53 in total

1.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

2.  Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.

Authors:  M M Levine; T P Hughes; C R Young; S O'Donnell; J P Craig; H P Holley; E J Bergquist
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

Review 3.  New-generation vaccines against cholera.

Authors:  John Clemens; Sunheang Shin; Dipika Sur; G Balakrish Nair; Jan Holmgren
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-08       Impact factor: 46.802

4.  Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.

Authors:  R K Gupta; S C Szu; R A Finkelstein; J B Robbins
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

5.  Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice.

Authors:  Julianne E Rollenhagen; Anuj Kalsy; Rina Saksena; Alaullah Sheikh; Mohammad Murshid Alam; Firdausi Qadri; Stephen B Calderwood; Pavol Kovác; Edward T Ryan
Journal:  Vaccine       Date:  2009-06-27       Impact factor: 3.641

6.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

7.  CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.

Authors:  J Michalski; J E Galen; A Fasano; J B Kaper
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.

Authors:  J W Peterson
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

9.  Kinetics of early cholera infection in the removable intestinal tie-adult rabbit diarrhea model.

Authors:  W M Spira; R B Sack
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

10.  Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.

Authors:  W C Cray; E Tokunaga; N F Pierce
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.